Dominic Moorhead

Dominic joined Ferring in July 2017 as Chief Financial Officer. He has been a strategic advisor to executives and investors in biotech.

Dominic has 30 years’ finance and business experience in the life sciences industry. Previously, he worked for Takeda Pharmaceuticals as Global Financial Controller, and CFO of the international business following the acquisition of Nycomed. Prior to this Dominic worked for Hoffmann-La Roche, where he was CFO of the Pharma Division for nine years during a period of transformation and growth. He was engaged in numerous strategic initiatives and business transactions, as well as their operational implications, culminating in the privatisation of Genentech in the U.S. in 2009.

Dominic has an ACA from Institute of Chartered Accountants in England and Wales and a BSc in Chemistry from the University of Nottingham.